Our latest survey shines a light on the realities of dementia diagnosis - what works, what gets in the way, and what needs to change.

The ADAPT trial forms part of the Blood Biomarker Challenge, a multi-million-pound programme supported by Alzheimer’s ...

Looking for some posters, materials, or guidance to help with your fundraising? You’re in the right place! You can download resources, order branded merchandise and ...

The information on these pages is for anyone who is concerned about symptoms of dementia, and for those who would like more information about how dementia is diagnosed. Anyone concerned about their ...

This distinguished group of some of the world’s leading dementia research experts reviews the applications we receive to most of our grant schemes before making recommendations to our Trustees.

People with dementia are at risk of missing out on new treatments if the UK does not improve how it hosts clinical trials, according to a new report from Alzheimer’s Research UK. Urgent reform is ...

Talks and Q&A with Dr Dennis Chan and Sarah Wilson on early detection and the EDoN initiative. Today, the diseases that cause dementia are diagnosed when symptoms like memory loss appear. To have the ...

Prof Catherine Lawrence, The University of Manchester Prof David Llewelyn, University of Exeter Dr Emma Mead, University of Oxford Dr Tim Rittman, University of Cambridge Prof Jessica Teeling, ...

Vice Presidents are Alzheimer’s Research UK’s highest-level Ambassadors, having shown long-standing commitment to the charity and dementia research more broadly. Working closely alongside the ...